359 related articles for article (PubMed ID: 33523588)
1. Elevation of EIF4G1 promotes non-small cell lung cancer progression by activating mTOR signalling.
Lu Y; Yu S; Wang G; Ma Z; Fu X; Cao Y; Li Q; Xu Z
J Cell Mol Med; 2021 Mar; 25(6):2994-3005. PubMed ID: 33523588
[TBL] [Abstract][Full Text] [Related]
2. Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.
Cao Y; Wei M; Li B; Liu Y; Lu Y; Tang Z; Lu T; Yin Y; Qin Z; Xu Z
Oncotarget; 2016 Apr; 7(17):24242-51. PubMed ID: 27003362
[TBL] [Abstract][Full Text] [Related]
3. Role of EIF4G1 network in non-small cell lung cancers (NSCLC) cell survival and disease progression.
Del Valle L; Dai L; Lin HY; Lin Z; Chen J; Post SR; Qin Z
J Cell Mol Med; 2021 Mar; 25(6):2795-2805. PubMed ID: 33539648
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and functional roles of EIF4G1 in lung squamous cell carcinoma.
Bai B; Dong L; Feng M; Zhang Z; Lu Y; Xu Z; Liu Y
Hum Cell; 2023 May; 36(3):1099-1107. PubMed ID: 36897548
[TBL] [Abstract][Full Text] [Related]
5. The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway.
Tian XP; Jin XH; Li M; Huang WJ; Xie D; Zhang JX
Mol Cancer; 2017 Apr; 16(1):74. PubMed ID: 28372542
[TBL] [Abstract][Full Text] [Related]
6. Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia.
Glück AA; Orlando E; Leiser D; Poliaková M; Nisa L; Quintin A; Gavini J; Stroka DM; Berezowska S; Bubendorf L; Blaukat A; Aebersold DM; Medová M; Zimmer Y
Oncogene; 2018 Jul; 37(30):4181-4196. PubMed ID: 29717265
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Tu L; Liu Z; He X; He Y; Yang H; Jiang Q; Xie S; Xiao G; Li X; Yao K; Fang W
Mol Cancer; 2010 Apr; 9():78. PubMed ID: 20398343
[TBL] [Abstract][Full Text] [Related]
9. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
[TBL] [Abstract][Full Text] [Related]
10. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
11. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
12. FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway.
Meng W; Meng J; Jiang H; Feng X; Wei D; Ding Q
Anal Cell Pathol (Amst); 2020; 2020():6021602. PubMed ID: 33354489
[TBL] [Abstract][Full Text] [Related]
13. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.
Van Nostrand JL; Brisac A; Mello SS; Jacobs SB; Luong R; Attardi LD
Cancer Discov; 2015 Jun; 5(6):622-35. PubMed ID: 25813352
[TBL] [Abstract][Full Text] [Related]
14. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
15. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
16. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
[TBL] [Abstract][Full Text] [Related]
17. TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway.
Zhang LX; Yang X; Wu ZB; Liao ZM; Wang DG; Chen SW; Lu F; Wu YB; Zhu SQ
Cancer Sci; 2023 Mar; 114(3):855-869. PubMed ID: 36403197
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail.
Deng M; Liu B; Zhang Z; Chen Y; Wang Y; Wang X; Lv Q; Yang X; Hou K; Che X; Qu X; Liu Y; Zhang Y; Hu X
Cancer Sci; 2020 Sep; 111(9):3210-3221. PubMed ID: 32519357
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of S6K1 promotes non-small cell lung cancer survival.
Mei H; Wang Y; Fan J; Lin Z
Tumour Biol; 2016 Oct; 37(10):13369-13376. PubMed ID: 27460085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]